Global Information
회사소개 | 문의 | 비교리스트

헤모글로빈 A1c 검사기기 시장 : 세계 업계 분석, 규모, 점유율, 성장, 동향, 예측

Hemoglobin A1c Testing Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

리서치사 Transparency Market Research
발행일 2019년 03월 상품 코드 301495
페이지 정보 영문 173 Pages
가격
US $ 5,795 ₩ 7,237,000 PDF by E-mail (Single user license) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. PDF 인쇄는 가능하지만, 전체 페이지 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 8,795 ₩ 10,984,000 PDF by E-mail (5-user license) help
5명까지 공유하여 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. PDF 전체 페이지 인쇄는 1명당 1회로 한정하며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 11,795 ₩ 14,730,000 PDF by E-mail (Corporate License) help
기업 내 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


헤모글로빈 A1c 검사기기 시장 : 세계 업계 분석, 규모, 점유율, 성장, 동향, 예측 Hemoglobin A1c Testing Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026
발행일 : 2019년 03월 페이지 정보 : 영문 173 Pages

세계의 헤모글로빈 A1c 검사기기(Hemoglobin A1c Testing Devices) 시장에 대해 조사했으며, 시장 동향과 부문별 동향, 지역별 예측, 시장 진출기업 개요에 대해 정리했습니다.

제1장 서론

제2장 전제조건과 약어

제3장 조사 방법

제4장 주요 요약

제5장 시장 개요

  • 제품 개요
  • 시장 역학
    • 성장 촉진요인
    • 성장 저해요인
    • 기회
  • 시장 규모 예측
  • 시장 전망
  • 업계의 발전
  • 시장 규제
  • 최근 인가된 브랜드
  • 정량 분석

제6장 기술별 시장 분석과 예측

  • 서론
  • 조사결과
  • 시장가치 점유율 분석
  • 시장 매출 예측
    • 이온 교환 고성능 액체 크로마토그래피
    • 면역측정
    • 보로네이트 친화력 크로마토그래피
    • 직접 효소 어세이
    • 기타
  • 시장 매력도

제7장 최종사용자별 시장 분석

  • 서론
  • 조사결과
  • 시장 매출 점유율 분석
  • 시장 매출 예측
    • 실험실 검사
    • Point of Care(POC) 시설
  • 시장 매력도

제8장 지역별 시장 분석과 예측

  • 서론
  • 지역별 전망
  • 시장 매출 예측
    • 북미
    • 유럽
    • 아시아태평양
    • 기타
  • 시장 매력도

제9장 북미 시장

제10장 유럽 시장

제11장 아시아태평양 시장

제12장 기타 국가

제13장 경쟁 환경

  • 경쟁 매트릭스
  • 시장 점유율 분석
  • 경쟁 비즈니스 전략
  • 기업 개요
LSH 19.05.23

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

List of Tables

  • Table 01: Global Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Technology, 2016-2026
  • Table 02: Global Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by End-user, 2016-2026
  • Table 03: Global Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Laboratories, 2016-2026
  • Table 04: Global Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Point-of-Care (POC) Settings, 2016-2026
  • Table 05: Global Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Region, 2016-2026
  • Table 06: North America Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Country, 2016-2026
  • Table 07: North America Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Technology, 2016-2026
  • Table 08: U.S. Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Technology, 2016-2026
  • Table 09: Canada Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Technology, 2016-2026
  • Table 10: North America Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by End-user, 2016-2026
  • Table 11: North America Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Laboratories, 2016-2026
  • Table 12: North America Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Point-of-Care (POC) Settings, 2016-2026
  • Table 13: U.S. Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by End-user, 2016-2026
  • Table 14: U.S. Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Laboratories, 2016-2026
  • Table 15: U.S. Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Point-of-Care (POC) Settings, 2016-2026
  • Table 16: Canada Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by End-user, 2016-2026
  • Table 17: Canada Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Laboratories, 2016-2026
  • Table 18: Canada Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Point-of-Care (POC) Settings, 2016-2026
  • Table 19: Europe Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016-2026
  • Table 20: Europe Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Technology, 2016-2026
  • Table 21: Europe Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by End-user, 2016-2026
  • Table 22: Europe Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Laboratory Testing End-user, 2016-2026
  • Table 23: Europe Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Point-of-Care (POC) Testing End-user, 2016-2026
  • Table 24: Asia Pacific Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016-2026
  • Table 25: Asia Pacific Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Technology, 2016-2026
  • Table 26: Asia Pacific Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by End-user, 2016-2026
  • Table 27: Asia Pacific Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Laboratories, 2016-2026
  • Table 28: Asia Pacific Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Point-of-Care (POC) Settings, 2016-2026
  • Table 29: Latin America Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016-2026
  • Table 30: Latin America Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Technology, 2016-2026
  • Table 31: Latin America Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by End-user, 2016-2026
  • Table 32: Latin America Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Laboratories, 2016-2026
  • Table 33: Latin America Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Point-of-Care (POC) Settings, 2016-2026
  • Table 34: Middle East & Africa Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016-2026
  • Table 35: Middle East & Africa Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Technology, 2016-2026
  • Table 36: Middle East & Africa Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by End-user, 2016-2026
  • Table 37: Middle East & Africa Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Laboratories, 2016-2026
  • Table 38: Middle East & Africa Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Point-of-Care (POC) Settings, 2016-2026

List of Figures

  • Figure 01: Global Hemoglobin A1c Testing Devices Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016-2026
  • Figure 02: Global Market Value Share, by Technology, 2017
  • Figure 03: Global Market Value Share, by Point-of-Care (POC) Settings, 2017
  • Figure 04: Global Market Value Share, by End-user, 2017
  • Figure 05: Global Market Value Share, by Region, 2017
  • Figure 06: North America Market Share (% ) of Laboratory Test
  • Figure 07: North America Market Share (%) of POC Test
  • Figure 08: Europe Market Share (%) of Laboratory Test
  • Figure 09: Europe Market Share (%) of POC Test
  • Figure 10: Asia Pacific Market Share (%) of Laboratory Test
  • Figure 11: Asia Pacific Market Share (%) of POC Test
  • Figure 12: Latin America Market Share (%) of Laboratory Test
  • Figure 13: Latin America Market Share (%) of POC Test
  • Figure 14: Middle East & Africa Market Share (%) of Laboratory Test
  • Figure 15: Asia Pacific Market Share (%) of POC Test
  • Figure 16: Global Hemoglobin A1c Testing Devices Market Value Share, by Technology, 2018 and 2026
  • Figure 17: Global Hemoglobin A1c Testing Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Ion-exchange HPLC, 2016-2026
  • Figure 18: Global Hemoglobin A1c Testing Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Immunoassay, 2016-2026
  • Figure 19: Global Hemoglobin A1c Testing Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Boronate Affinity Chromatography, 2016-2026
  • Figure 20: Global Hemoglobin A1c Testing Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Direct Enzymatic Assay, 2016-2026
  • Figure 21: Global Hemoglobin A1c Testing Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2016-2026
  • Figure 22: Global Hemoglobin A1c Testing Devices Market Attractiveness, by Technology, 2018-2026
  • Figure 23: Global Hemoglobin A1c Testing Devices Market Value Share, by End-user, 2018 and 2026
  • Figure 24: Global Hemoglobin A1c Testing Devices Market Attractiveness, by End-user, 2018-2026
  • Figure 25: Global Hemoglobin A1c Testing Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Laboratories, 2016-2026
  • Figure 26: Global Hemoglobin A1c Testing Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Point-of-Care (POC) Settings, 2016-2026
  • Figure 27: Global Hemoglobin A1c Testing Devices Market Value Share, by Region, 2018 and 2026
  • Figure 28: Global Hemoglobin A1c Testing Devices Market Attractiveness, by Region, 2018-2026
  • Figure 29: North America Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016-2026
  • Figure 30: North America Hemoglobin A1c Testing Devices Market Value Share, by Country, 2018-2026
  • Figure 31: North America Hemoglobin A1c Testing Devices Market Attractiveness, by Country, 2018-2026
  • Figure 32: North America Hemoglobin A1c Testing Devices Market Value Share, by Technology, 2018 and 2026
  • Figure 33: North America Hemoglobin A1c Testing Devices Market Attractiveness, by Technology, 2018-2026
  • Figure 34: North America Hemoglobin A1c Testing Devices Market Value Share, by End-user, 2018 and 2026
  • Figure 35: North America Hemoglobin A1c Testing Devices Market Attractiveness, by End-user, 2018-2026
  • Figure 36: Europe Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016-2026
  • Figure 37: Europe Hemoglobin A1c Testing Devices Market Value Share, by Country/Sub-Region, 2018-2026
  • Figure 38: Europe Hemoglobin A1c Testing Devices Market Attractiveness, by Country/Sub-Region, 2018-2026
  • Figure 39: Europe Hemoglobin A1c Testing Devices Market Value Share, by Technology, 2018 and 2026
  • Figure 40: Europe Hemoglobin A1c Testing Devices Market Attractiveness, by Technology, 2018-2026
  • Figure 41: Europe Hemoglobin A1c Testing Devices Market Value Share, by End-user, 2018 and 2026
  • Figure 42: Europe Hemoglobin A1c Testing Devices Market Attractiveness, by End-user, 2018-2026
  • Figure 43: Asia Pacific Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016-2026
  • Figure 44: Asia Pacific Hemoglobin A1c Testing Devices Market Value Share, by Country/Sub-Region, 2018-2026
  • Figure 45: Asia Pacific Hemoglobin A1c Testing Devices Market Attractiveness, by Country/Sub-Region, 2018-2026
  • Figure 46: Asia Pacific Hemoglobin A1c Testing Devices Market Value Share, by Technology, 2018 and 2026
  • Figure 47: Asia Pacific Hemoglobin A1c Testing Devices Market Attractiveness, by Technology, 2018-2026
  • Figure 48: Asia Pacific Hemoglobin A1c Testing Devices Market Value Share, by End-user, 2018 and 2026
  • Figure 49: Asia Pacific Hemoglobin A1c Testing Devices Market Attractiveness, by End-user, 2018-2026
  • Figure 50: Latin America Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016-2026
  • Figure 51: Latin America Hemoglobin A1c Testing Devices Market Value Share, by Country/Sub-Region, 2018-2026
  • Figure 52: Latin America Hemoglobin A1c Testing Devices Market Attractiveness, by Country/Sub-region, 2018-2026
  • Figure 53: Latin America Hemoglobin A1c Testing Devices Market Value Share, by Technology, 2018 and 2026
  • Figure 54: Latin America Hemoglobin A1c Testing Devices Market Attractiveness, by Technology, 2018-2026
  • Figure 55: Latin America Hemoglobin A1c Testing Devices Market Value Share, by End-user, 2018 and 2026
  • Figure 56: Latin America Hemoglobin A1c Testing Devices Market Attractiveness, by End-user, 2018-2026
  • Figure 57: Middle East & Africa Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016-2026
  • Figure 58: Middle East & Africa Hemoglobin A1c Testing Devices Market Value Share, by Country/Sub-region, 2018 and 2026
  • Figure 59: Middle East & Africa Hemoglobin A1c Testing Devices Market Attractiveness, by Country/Sub-region, 2018-2026
  • Figure 60: Middle East & Africa Hemoglobin A1c Testing Devices Market Value Share, by Technology, 2018 and 2026
  • Figure 61: Middle East & Africa Hemoglobin A1c Testing Devices Market Attractiveness, by Technology, 2018-2026
  • Figure 62: Middle East & Africa Hemoglobin A1c Testing Devices Market Value Share, by End-user, 2018 and 2026
  • Figure 63: Middle East & Africa Hemoglobin A1c Testing Devices Market Attractiveness, by End-user, 2018-2026
  • Figure 64: Global Hemoglobin A1c Testing Devices Market Analysis, by Top Company Ranking, 2017

Title:
Hemoglobin A1c Testing Devices Market (Technology - Ion-exchange High-performance Liquid Chromatography (HPLC), Immunoassay, Boronate Affinity Chromatography, Direct Enzymatic Assay; End user - Laboratory Testing (Commercial Laboratory and Others), Point-of-care (POC) Settings (Hospitals, Home Care, Clinics)) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026.

Global Hemoglobin A1c Testing Devices Market: Overview

The global hemoglobin A1c testing devices market report comprises an elaborate executive summary, which includes a snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on technology, end-user, and region. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the overview section. Additionally, the section comprises a competitive matrix and company profiles along with business overview to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis, by geography, thereby presenting a thorough analysis of the overall competitive scenario in the global hemoglobin A1c testing devices market.

Global Hemoglobin A1c Testing Devices Market: Key Segments

In terms of technology, the global hemoglobin A1c testing devices market has been segmented into ion-exchange high-performance liquid chromatography (hplc), immunoassay, boronate affinity chromatography, direct enzymatic assay, and others. Based on end-user, the market has been classified into laboratories testing and point-of-care (POC) settings. The laboratories testing segment has been further segmented into commercial laboratory and others. The point-of-care (POC) settings segment has been further categorized into hospitals, home care, clinics, and others. The POC settings segment is anticipated to expand at a significant CAGR during the forecast period. The market has been analyzed based on price variations, technology trends, and presence of key players. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.

Global Hemoglobin A1c Testing Devices Market: Regional Outlook

In terms of region, the global hemoglobin A1c testing devices market has been segmented into five major regions: North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (China, India, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East (South Africa, GCC Countries, and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in Report

The report also profiles major players in the market in terms of attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Key companies profiled in the global hemoglobin A1c testing devices market include Siemens Healthineers, Abbott Laboratories, Arkray, Inc., Bio-Rad Laboratories, Inc., Polymer Technology Systems, Inc., Danaher Corporation (Beckman Coulter), EKF Diagnostics Holdings plc, F. Hoffmann-La Roche Ltd., Menarini Group, Sebia, Tosoh Corporation, and Trinity Biotech plc.

The global hemoglobin A1c testing devices market has been segmented as follows:

Global Hemoglobin A1c Testing Devices Market, by Technology

  • Ion-exchange High-performance Liquid Chromatography (HPLC)
  • Immunoassay
  • Boronate Affinity Chromatography
  • Direct Enzymatic Assay
  • Others

Global Hemoglobin A1c Testing Devices Market, by End-user

  • Laboratory Testing End-user
    • Commercial Laboratory
    • Others
  • Point-of-care (POC) Testing End-user
    • Hospitals
    • Home Care
    • Clinics
    • Others

Global Hemoglobin A1c Testing Devices Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • Australia
    • India
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • South Africa
    • GCC Countries
    • Israel
    • Rest of Middle East & Africa

Table of Contents

1. Preface

  • 1.1. Report Scope and Market Segmentation
  • 1.2. Research Highlights

2. Assumptions and Acronyms Used

3. Research Methodology

4. Executive Summary

5. Market Overview

  • 5.1. Product Overview
  • 5.2. Market Dynamics
    • 5.2.1. Drivers
      • 5.2.1.1. High Prevalence and Increase in the Incidence of Diabetes
      • 5.2.1.2. Increase in the Geriatric Population
      • 5.2.1.3. Employer Sponsored Medical Programs
      • 5.2.1.4. Improving Health Care Facilities
      • 5.2.1.5. Growing Medical Tourism
    • 5.2.2. Restraints
      • 5.2.2.1. Absence of Health Insurance Schemes in Developing Countries
      • 5.2.2.2. Lack of Medical Professionals in Developing Countries
    • 5.2.3. Opportunities
      • 5.2.3.1. Unmet Clinical Needs in Developing Countries
      • 5.2.3.2. Technologically Advanced and Innovative Solutions
  • 5.3. Global Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, 2016?2026
  • 5.4. Global Hemoglobin A1c Testing Devices Market Outlook
  • 5.5. Key Industry Developments
  • 5.6. Market Regulations
    • 5.6.1. U.S. Regulations for Medical Devices
    • 5.6.2. Europe: Regulations for Medical Devices
    • 5.6.3. Asia Pacific: Regulations
  • 5.7. Recent Approved Brands for HbA1c Test, 2018
  • 5.8. Quantitative Analysis, by Test Type

6. Global Hemoglobin A1c Testing Devices Market Analysis, by Technology

  • 6.1. Introduction
  • 6.2. Key Findings
  • 6.3. Global Hemoglobin A1c Testing Devices Market Value Share Analysis, by Technology
  • 6.4. Global Hemoglobin A1c Testing Devices Market Value Forecast, by Technology, 2016?2026
    • 6.4.1. Ion-exchange High-performance Liquid Chromatography (HPLC)
    • 6.4.2. Immunoassay
    • 6.4.3. Boronate Affinity Chromatography
    • 6.4.4. Direct Enzymatic Assay
    • 6.4.5. Others
  • 6.5. Global Hemoglobin A1c Testing Devices Market Attractiveness, by Technology

7. Global Hemoglobin A1c Testing Devices Market Analysis, by End-user

  • 7.1. Introduction
  • 7.2. Key Findings
  • 7.3. Market Value Share Analysis, by End-user
  • 7.4. Market Value Forecast, by End-user, 2016-2026
    • 7.4.1. Laboratory Testing End-user
      • 7.4.1.1. Commercial Laboratory
      • 7.4.1.2. Others
    • 7.4.2. Point-of-care (POC) Setting
      • 7.4.2.1. Hospitals
      • 7.4.2.2. Home Care
      • 7.4.2.3. Clinics
      • 7.4.2.4. Others
  • 7.5. Market Attractiveness, by End-user

8. Global Hemoglobin A1c Testing Devices Market Analysis and Forecasts, by Region

  • 8.1. Introduction
  • 8.2. Regional Outlook
  • 8.3. Global Hemoglobin A1c Testing Devices Market Value Forecast, by Region, 2016-2026
    • 8.3.1. North America
    • 8.3.2. Europe
    • 8.3.3. Asia Pacific
    • 8.3.4. Rest of the World
  • 8.4. Global Hemoglobin A1c Testing Devices Market Attractiveness Analysis, by Region

9. North America Hemoglobin A1c Testing Devices Market Analysis

  • 9.1. Key Findings
  • 9.2. North America Market Value Forecast, by Country, 2016?2026
    • 9.2.1. U.S.
    • 9.2.2. Canada
  • 9.3. North America Market Value Forecast, by Technology, 2016?2026
    • 9.3.1. Ion-exchange High-performance Liquid Chromatography (HPLC)
    • 9.3.2. Immunoassay
    • 9.3.3. Boronate Affinity Chromatography
    • 9.3.4. Direct Enzymatic Assay
    • 9.3.5. Others
  • 9.4. North America Market Value Forecast, by End-user, 2016-2026
    • 9.4.1. Laboratory Testing End-user
      • 9.4.1.1. Commercial Laboratory
      • 9.4.1.2. Others
    • 9.4.2. Point-of-care (POC) Setting
      • 9.4.2.1. Hospitals
      • 9.4.2.2. Home Care
      • 9.4.2.3. Clinics
      • 9.4.2.4. Others
  • 9.5. North America Market Attractiveness Analysis
    • 9.5.1. By Country
    • 9.5.2. By Technology
    • 9.5.3. By End-user

10. Europe Hemoglobin A1c Testing Devices Market Analysis

  • 10.1. Key Findings
  • 10.2. Europe Market Value Forecast, by Country, 2016?2026
    • 10.2.1. Germany
    • 10.2.2. U.K.
    • 10.2.3. France
    • 10.2.4. Italy
    • 10.2.5. Spain
    • 10.2.6. Rest of Europe
  • 10.3. Europe Market Value Forecast, by Technology, 2016?2026
    • 10.3.1. Ion-exchange High-performance Liquid Chromatography (HPLC)
    • 10.3.2. Immunoassay
    • 10.3.3. Boronate Affinity Chromatography
    • 10.3.4. Direct Enzymatic Assay
    • 10.3.5. Others
  • 10.4. Europe Market Value Forecast, by End-user, 2016-2026
    • 10.4.1. Laboratory Testing End-user
      • 10.4.1.1. Commercial Laboratory
      • 10.4.1.2. Others
    • 10.4.2. Point-of-care (POC) Setting
      • 10.4.2.1. Hospitals
      • 10.4.2.2. Home Care
      • 10.4.2.3. Clinics
      • 10.4.2.4. Others
  • 10.5. Europe Market Attractiveness Analysis
    • 10.5.1. By Country
    • 10.5.2. By Technology
    • 10.5.3. By End-user

11. Asia Pacific Hemoglobin A1c Testing Devices Market Analysis

  • 11.1. Key Findings
  • 11.2. Asia Pacific Market Value Forecast, by Country, 2016?2026
    • 11.2.1. China
    • 11.2.2. India
    • 11.2.3. Japan
    • 11.2.4. Australia & New Zealand
    • 11.2.5. Rest of Asia Pacific
  • 11.3. Asia Pacific Market Value Forecast, by Technology, 2016?2026
    • 11.3.1. Ion-exchange High-performance Liquid Chromatography (HPLC)
    • 11.3.2. Immunoassay
    • 11.3.3. Boronate Affinity Chromatography
    • 11.3.4. Direct Enzymatic Assay
    • 11.3.5. Others
  • 11.4. Asia Pacific Market Value Forecast, by End-user, 2016-2026
    • 11.4.1. Laboratory Testing End-user
      • 11.4.1.1. Commercial Laboratory
      • 11.4.1.2. Others
    • 11.4.2. Point-of-care (POC) Setting
      • 11.4.2.1. Hospitals
      • 11.4.2.2. Home Care
      • 11.4.2.3. Clinics
      • 11.4.2.4. Others
  • 11.5. Asia Pacific Market Attractiveness Analysis
    • 11.5.1. By Country
    • 11.5.2. By Technology
    • 11.5.3. By End-user

12. Rest of the World Hemoglobin A1c Testing Devices Market Analysis

  • 12.1. Key Findings
  • 12.2. Rest of the World Market Value Forecast, by Country, 2016?2026
    • 12.2.1. Brazil
    • 12.2.2. GCC Countries
    • 12.2.3. Rest of the World
  • 12.3. Rest of the World Market Value Forecast, by Technology, 2016?2026
    • 12.3.1. Ion-exchange High-performance Liquid Chromatography (HPLC)
    • 12.3.2. Immunoassay
    • 12.3.3. Boronate Affinity Chromatography
    • 12.3.4. Direct Enzymatic Assay
    • 12.3.5. Others
  • 12.4. Rest of the World Market Value Forecast, by End-user, 2016-2026
    • 12.4.1. Laboratory Testing End-user
      • 12.4.1.1. Commercial Laboratory
      • 12.4.1.2. Others
    • 12.4.2. Point-of-care (POC) Setting
      • 12.4.2.1. Hospitals
      • 12.4.2.2. Home Care
      • 12.4.2.3. Clinics
      • 12.4.2.4. Others
  • 12.5. Asia Pacific Market Attractiveness Analysis
    • 12.5.1. By Country
    • 12.5.2. By Technology
    • 12.5.3. By End-user

13. Competitive Landscape

  • 13.1. Market Player - Competition Matrix (By Tier and Size of companies) Company Profiles
  • 13.2. Market Share Analysis, by Top Company Ranking, 2017
  • 13.3. Competitive Business Strategies
  • 13.4. Company Profiles
    • 13.4.1. Abbott Laboratories
      • 13.4.1.1. Company Overview (Headquarters, Business Segments, Employee Strength)
      • 13.4.1.2. Financial Overview
      • 13.4.1.3. Product Portfolio
      • 13.4.1.4. SWOT Analysis
      • 13.4.1.5. Strategic Overview
    • 13.4.2. Arkray, Inc.
      • 13.4.2.1. Company Overview (Headquarters, Business Segments, Employee Strength)
      • 13.4.2.2. Financial Overview
      • 13.4.2.3. Product Portfolio
      • 13.4.2.4. SWOT Analysis
      • 13.4.2.5. Strategic Overview
    • 13.4.3. Bio-Rad Laboratories, inc.
      • 13.4.3.1. Company Overview (Headquarters, Business Segments, Employee Strength)
      • 13.4.3.2. Financial Overview
      • 13.4.3.3. Product Portfolio
      • 13.4.3.4. SWOT Analysis
      • 13.4.3.5. Strategic Overview
    • 13.4.4. Polymer Technology Systems, Inc.
      • 13.4.4.1. Company Overview (Headquarters, Business Segments, Employee Strength)
      • 13.4.4.2. Financial Overview
      • 13.4.4.3. Product Portfolio
      • 13.4.4.4. SWOT Analysis
      • 13.4.4.5. Strategic Overview
    • 13.4.5. Danaher Corporation (Beckman Coulter)
      • 13.4.5.1. Company Overview (Headquarters, Business Segments, Employee Strength)
      • 13.4.5.2. Financial Overview
      • 13.4.5.3. Product Portfolio
      • 13.4.5.4. SWOT Analysis
      • 13.4.5.5. Strategic Overview
    • 13.4.6. EKF Diagnostics Holdings plc
      • 13.4.6.1. Company Overview (Headquarters, Business Segments, Employee Strength)
      • 13.4.6.2. Financial Overview
      • 13.4.6.3. Product Portfolio
      • 13.4.6.4. SWOT Analysis
      • 13.4.6.5. Strategic Overview
    • 13.4.7. F. Hoffmann-La Roche Ltd.
      • 13.4.7.1. Company Overview (Headquarters, Business Segments, Employee Strength)
      • 13.4.7.2. Financial Overview
      • 13.4.7.3. Product Portfolio
      • 13.4.7.4. SWOT Analysis
      • 13.4.7.5. Strategic Overview
    • 13.4.8. Menarini Group
      • 13.4.8.1. Company Overview (Headquarters, Business Segments, Employee Strength)
      • 13.4.8.2. Financial Overview
      • 13.4.8.3. Product Portfolio
      • 13.4.8.4. SWOT Analysis
      • 13.4.8.5. Strategic Overview
    • 13.4.9. Sebia
      • 13.4.9.1. Company Overview (Headquarters, Business Segments, Employee Strength)
      • 13.4.9.2. Financial Overview
      • 13.4.9.3. Product Portfolio
      • 13.4.9.4. SWOT Analysis
      • 13.4.9.5. Strategic Overview
    • 13.4.10. Tosoh Corporation
      • 13.4.10.1. Company Overview (Headquarters, Business Segments, Employee Strength)
      • 13.4.10.2. Financial Overview
      • 13.4.10.3. Product Portfolio
      • 13.4.10.4. SWOT Analysis
      • 13.4.10.5. Strategic Overview
    • 13.4.11. Trinity Biotech plc.
      • 13.4.11.1. Company Overview (Headquarters, Business Segments, Employee Strength)
      • 13.4.11.2. Financial Overview
      • 13.4.11.3. Product Portfolio
      • 13.4.11.4. SWOT Analysis
      • 13.4.11.5. Strategic Overview
Back to Top
전화 문의
F A Q